First Trust NYSE Arca Biotechnology Index Fund
0
Funds holding %
of 7,425 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
92% more capital invested
Capital invested by funds: $575M [Q3] → $1.1B (+$527M) [Q4]
10% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 30
3% more repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 79
0% more funds holding in top 10
Funds holding in top 10: 1 [Q3] → 1 (+0) [Q4]
0.48% less ownership
Funds ownership: 51.84% [Q3] → 51.36% (-0.48%) [Q4]
1% less funds holding
Funds holding: 255 [Q3] → 252 (-3) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for FBT.
Financial journalist opinion
Neutral
Zacks Investment Research
6 days ago
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
Designed to provide broad exposure to the Health Care ETFs category of the market, the First Trust NYSE Arca Biotechnology ETF (FBT) is a smart beta exchange traded fund launched on 06/19/2006.
Neutral
Zacks Investment Research
2 weeks ago
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the First Trust NYSE Arca Biotechnology ETF (FBT) is a passively managed exchange traded fund launched on 06/19/2006.
Neutral
Seeking Alpha
2 months ago
Seeking Stocks With Vitality In The Volatile Healthcare Sector
Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?
Neutral
Zacks Investment Research
2 months ago
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
The First Trust NYSE Arca Biotechnology ETF (FBT) was launched on 06/19/2006, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.
Neutral
Zacks Investment Research
2 months ago
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the First Trust NYSE Arca Biotechnology ETF (FBT), a passively managed exchange traded fund launched on 06/19/2006.
Neutral
Zacks Investment Research
4 months ago
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
A smart beta exchange traded fund, the First Trust NYSE Arca Biotechnology ETF (FBT) debuted on 06/19/2006, and offers broad exposure to the Health Care ETFs category of the market.
Neutral
Zacks Investment Research
4 months ago
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the First Trust NYSE Arca Biotechnology ETF (FBT) is a passively managed exchange traded fund launched on 06/19/2006.
Neutral
Zacks Investment Research
6 months ago
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
The First Trust NYSE Arca Biotechnology ETF (FBT) was launched on 06/19/2006, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.
Neutral
Zacks Investment Research
6 months ago
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the First Trust NYSE Arca Biotechnology ETF (FBT) is a passively managed exchange traded fund launched on 06/19/2006.
Neutral
Zacks Investment Research
8 months ago
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
The First Trust NYSE Arca Biotechnology ETF (FBT) made its debut on 06/19/2006, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.
Charts implemented using Lightweight Charts™